The effect of aminoguanidine on compression spinal cord injury in rats

Brain Research

Volumn 1342, Issue , 2010, Pages 1-10

  Fan, Zhong kai ^a,b   Wang, Yan feng ^a   Cao, Yang ^b   Zhang, Ming chao ^b   Zhang, Zheng ^b   Lv, Gang ^a   Lu, Wei ^b   Zhang, Yu qiang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Aminoguanidine; Aquaporin 4; Glutathione; iNOS; Malondialdehyde; Spinal cord edema; Spinal cord injury

Indexed keywords

AMINOGUANIDINE; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; WATER CONTENT; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; EDEMA; GUANIDINES; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES;

RATTUS;

EID: 77953286013     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.04.038     Document Type: Article

References (23)

1. Abdel-Rahman E., and Bolto W.K. Pimagedin: a novel therapy for diabetic nephropathy. Expert Opin. Investig. Drugs 11 (2002) 565-574
2. Ayer R.E., and Zhang J.H. Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury. Acta Neurochir. Suppl. 104 (2008) 33-41
3. Cash D., Beech J.S., Rayne R.C., Bath P.M., Meldrum B.S., and Williams S.C. Neuroprotective effect of aminoguanidine on transient focal ischaemia in the rat brain. Brain Res. 29 (2001) 91-103
4. Chatzipanteli K., Garcia R., Marcillo A.E., Loor K.E., Kraydieh S., and Dietrich W.D. Temporal and segmental distribution of constitutive and inducible nitric oxide synthases after traumatic spinal cord injury: effect of aminoguanidine treatment. J. Neurotrauma 19 (2002) 639-651
5. Cohen D.M., Patel C.B., Ahobila-Vajjula P., Sundberg L.M., Chacko T., Liu S.J., and Narayana P.A. Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI. NMR Biomed. 22 (2008) 332-341
6. Di F., Yan-Ting G., Hui L., Tao T., Zai-Hua X., Xue-Ying S., Hong-Li X., and Yun-Jie W. Role of aminoguanidine in brain protection in surgical brain injury in rat. Neurosci. Lett. 448 (2008) 204-207
7. Fujiki M., Furukawa Y., Kobayashi H., et al. Geranylgeranylacetone limits secondary injury, neuronal death, and progressive necrosis and cavitation after spinal cord injury. Brain Res. 1053 (2005) 175-184
8. Huang W.L., George K.J., Ibba V., Liu M.C., Averill S., Quartu M., et al. The characteristics of neuronal injury in a static compression model of spinal cord injury in adult rats. Eur. J. Neurol. 25 (2007) 362-372
9. Kazachkov M., Chen K., Babiy S., and Yu P.H. Evidence for in vivo scavenging by aminoguanidine of formaldehyde produced via semicarbazide-sensitive amine oxidase-mediated deamination. J. Pharmacol. Exp. Ther. 322 (2007) 1201-1207
10. Levine R.L., Williams J.A., Stadtman E.R., and Shacter E. Carbonyl assays for determination of oxidatively mdified protein. Methods Enzymol. 233 (1994) 346-357
11. Leypold B.G., Flanders A.E., and Burns A.S. The early evolution of spinal cord lesions on MR imaging following traumatic spinal cord injury. AJNR Am. J. Neuroradiol. 29 (2008) 1012-1016
12. Louin G., Marchand-Verrecchia C., Palmier B., Plotkine M., and Jafarian-Tehrani M. Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury. Neuropharmacology 50 (2006) 182-190
13. Nesic O., Lee J., Ye Z., Unabia G.C., Rafati D., Hulsebosch C.E., and Perez-Polo J.R. Acute and chronic changes in aquaporin 4 expression after spinal cord injury. Neuroscience 143 (2006) 779-792
14. Pearse D.D., Chatzipanteli K., Marcillo A.E., Bunge M.B., and Dietrich W.D. Comparison of iNOS inhibition by antisense and pharmacological inhibitors after spinal cord injury. J. Neuropathol. Exp. Neurol. 62 (2003) 1096-1107
15. Saadoun S., Bell B.A., Verkman A.S., and Papadopoulos M.C. Greatly improved neurological outcome after spinal cord compression injury inAQP4-deficient mice. Brain 131 (2008) 1087-1098
16. Sharma H.S., Westman J., Olsson Y., and Alm P. Involvement of nitric oxide in acute spinal cord injury: an immunocytochemical study using light and electron microscopy in the rat. Neurosci. Res. 24 (1996) 373-384
17. Sharma H.S., Sjöquist P.O., Mohanty S., and Wiklund L. Post-injury treatment with a new antioxidant compound H-290/51 attenuates spinal cord trauma-induced c-fos expression, motor dysfunction, edema formation, and cell injury in the rat. Acta Neurochir. Suppl. 96 (2006) 322-328
18. Sugimoto K., and Iadecola C. Effects of aminoguanidine on cerebral ischemia in mice: comparison between mice with and without inducible nitric oxide synthase gene. Neurosci. Lett. 331 (2002) 25-28
19. Tomas-Camardiel M., Venero J.L., Herrera A.J., De Pablos R.M., Pintor-Toro J.A., Machado A., and Cano J. Blood-brain barrier disruption highly induces aquaporin-4 mRNA and protein in perivascular and parenchymal astrocytes: protective effect by estradiol treatment in ovariectomized animals. J. Neurosci. Res. 80 (2005) 235-246
20. Vermeulen N.P.E., and Baldew G.S. The role of lipid peroxidation in the nephrotoxicity of cisplatin. Biochem. Pharmacol. 44 (1992) 1193-1199
21. Wyndaele M., and Wyndaele J.J. Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey?. Spinal Cord 44 (2006) 523-529
22. Xu W.B., Gu Y.T., Wang Y.F., Lu X.H., Jia L.S., and Lv G. Bradykinin preconditioning modulates aquaporin-4 expression after spinal cord ischemic injury in rats. Brain Res. 1246 (2008) 11-18
23. Zhang X.Y., Zhou C.S., Jin A.M., Tian J., Zhang H., Yao W.T., and Zheng G. Effect of aminoguanidine on the recovery of rat hindlimb motor function after spinal cord injury. Di Yi Jun Yi Da Xue Xue Bao 23 (2003) 687-689